Haleon plc (ETR:H6D0)

Market Cap	39.96B
Revenue (ttm)	13.58B
Net Income (ttm)	1.74B
Shares Out	n/a
EPS (ttm)	0.19
PE Ratio	22.92
Forward PE	n/a
Dividend	0.02 (0.54%)
Ex-Dividend Date	Apr 24, 2025

Volume	1
Average Volume	1,945
Open	4.403
Previous Close	4.316
Day's Range	4.367 - 4.403
52-Week Range	3.700 - 5.110
Beta	n/a
RSI	43.00
Earnings Date	Jul 31, 2025

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 24,561
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: H6D0

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.

Financial numbers in GBP